MarketCapTrends
DNA
Ginkgo Bioworks Holdings Inc. (DNA)
NYSE · Healthcare

Ginkgo Bioworks Holdings Inc. Cash on Hand 2019–2025

Ginkgo Bioworks Holdings Inc. annual/quarterly cash on hand history from 2020 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.

  • Ginkgo Bioworks Holdings Inc. cash on hand for the quarter ending December 31, 2025 were 167.2M, a 70.23% decrease year-over-year.
  • Ginkgo Bioworks Holdings Inc. cash on hand for 2025 were 167.2M, a 70.23% decrease from 2024.
  • Ginkgo Bioworks Holdings Inc. cash on hand for 2024 were 561.6M, a 40.52% decrease from 2023.
  • Ginkgo Bioworks Holdings Inc. cash on hand for 2023 were 944.1M, a 28.25% decrease from 2022.
  • Ginkgo Bioworks Holdings Inc. cash on hand for 2022 were 1.32B.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Ginkgo Bioworks Holdings Inc. Annual Cash on Hand (Millions of US $)
2025$167
2024$562
2023$944
2022$1,316
2021$1,550
2020$381
Ginkgo Bioworks Holdings Inc. Quarterly Cash on Hand (Millions of US $)
2025-12-31$167
2024-12-31$562
2023-12-31$944
2022-12-31$1,316
2021-12-31$1,550
2020-12-31$381

Ginkgo Bioworks Holdings Inc. Cash on Hand — FAQ

Ginkgo Bioworks Holdings Inc. (DNA) cash on hand over the last 7 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see DNA's cash on hand history?

The chart and table above show Ginkgo Bioworks Holdings Inc.'s cash on hand by year and by quarter, including the growth rate.